Theresa Wingrove, SVP OF REGULATORY AFFAIRS at ImmunoGen, Inc. (IMGN), sold 333,450 shares at $15.85 ($5.3M) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Scheduled sale ($5.3M) by SVP OF REGULATORY AFFAIRS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.85 | 166,725 | $2.6M | 50.0% |
| 2 | $15.85 | 166,725 | $2.6M | 50.0% |
| Total | $15.85 avg | 333,450 | $5.3M | 100% |
| Filing → |
| IMGN | SELL | 2023-12-19 | $3.5M | — | Filing → |
| IMGN | SELL | 2023-12-01 | $9.7M | — | Filing → |
| IMGN | SELL | 2023-11-08 | $650K | — | Filing → |